3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
25
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
22
Lymphoma
18
Leukemia, Lymphocytic, Chronic, B-Cell
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma, Non-Hodgkin
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Hodgkin Disease
15
Multiple Myeloma
11
Hematologic Neoplasms
11
Primary Myelofibrosis
9
Myeloproliferative Disorders
9
Lymphoma, Mantle-Cell
8
Lymphoma, Large B-Cell, Diffuse
8
Graft vs Host Disease
8
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myelomonocytic, Juvenile
6
Leukemia, Myelomonocytic, Chronic
6
Burkitt Lymphoma
6
Leukemia, Myeloid, Accelerated Phase
5
Waldenstrom Macroglobulinemia
4
Neoplasms
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Extranodal NK-T-Cell
4
Leukemia, Neutrophilic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Congenital Abnormalities
4
Interventions
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Opsoclonus-Myoclonus Syndrome
×
thymoglobulin
×
Clear all
No trials found.